1985
DOI: 10.1152/ajpheart.1985.249.6.h1070
|View full text |Cite
|
Sign up to set email alerts
|

Alpha 1-adrenergic blockade increases coronary blood flow during coronary hypoperfusion

Abstract: Coronary hypoperfusion was elicited in alpha-chloralose-anesthetized open-chest dogs by reducing left coronary perfusion pressure to 50 mmHg. Left coronary blood flow, as well as left ventricular oxygen extraction, oxygen consumption, and contractile force were measured. The reduction in perfusion pressure caused significant reductions in coronary flow, oxygen consumption, and peak reactive hyperemic flow. During hypoperfusion in 11 dogs, intracoronary infusion of the specific alpha 1-adrenergic antagonist pra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

1987
1987
2008
2008

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Thus, phentolamine prevented sympathetic poststenotic coronary constriction. The presence of alpha-adrenergic constrictor tone during coronary hypoperfusion was also confirmed by Liang and Jones [48]. The selective alpha~-adrenoceptor antagonist rauwolscine, in an equihypotensive dose, however, was equally effective as phentolamine ( Figure 3).…”
Section: Alpha-adrenergic Coronary Constriction and Myocardial Ischemiamentioning
confidence: 55%
“…Thus, phentolamine prevented sympathetic poststenotic coronary constriction. The presence of alpha-adrenergic constrictor tone during coronary hypoperfusion was also confirmed by Liang and Jones [48]. The selective alpha~-adrenoceptor antagonist rauwolscine, in an equihypotensive dose, however, was equally effective as phentolamine ( Figure 3).…”
Section: Alpha-adrenergic Coronary Constriction and Myocardial Ischemiamentioning
confidence: 55%
“…8,9 Moreover, relief of ␣-adrenergic constrictor tone has clearly been shown to increase coronary blood flow in experimental models of hypoperfusion. 29 Whether ␣-adrenergic receptor blockers would improve resting dysfunction and contractile reserve in patients with myocardial hibernation remains to be determined. Ultimately, whether the alterations observed in adrenergic receptor density in myocardial hibernation are reversible after revascularization and account in part for the recovery of resting function would be difficult to answer clinically and would await confirmation in an experimental model.…”
Section: Adrenergic Receptors and Contractile Functionmentioning
confidence: 99%
“…Coronary vasoconstriction in β -adrenoceptor-blocked hearts can be elicited by injection of phenylephrine and other α -adrenergic agonists. During conditions such as hypotension [85,[101][102][103] and myocardial ischemia [85,98,104] , in which myocardial oxygen delivery is impaired, adrenergic constriction competes with vasodilation produced by local metabolic mechanisms. They found that at the same level of myocardial oxygen consumption, blood flow was significantly higher in the presence of α -adrenergic blockade.…”
Section: Sympathetic Controlmentioning
confidence: 99%
“…They found that at the same level of myocardial oxygen consumption, blood flow was significantly higher in the presence of α -adrenergic blockade. Similarly, coronary blood flow increases during hypotension following α-adrenergic [101][102][103] . Studies in exercising animals have shown that α -adrenergic constriction restricts coronary blood flow during exercise [92,93,94,95,99,100] .…”
Section: Sympathetic Controlmentioning
confidence: 99%